Medical News

RSS

FDA approves Baxter's TISSEEL for general hemostasis in surgery

Baxter International Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved TISSEEL [Fibrin Sealant] to include general hemostasis in surgery when control of bleeding by standard surgical techniques is ineffective or impractical.

From Baxter International Inc. 30 Jan 2012

FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds

Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms.

From Medtronic 30 Jan 2012

Reflecting on Africa's successes, challenges in fight against malaria

Ellen Johnson Sirleaf, president of Liberia and the new chair of the African Leaders Malaria Alliance (ALMA), writes in a Huffington Post opinion piece about Africa's efforts in the fight against malaria.

30 Jan 2012

New HIS guidelines to minimise surgical infection in day centres and primary care

New guidelines from the Healthcare Infection Society (HIS) aimed at minimising surgical infection in day centres and primary care are now published in The Journal of Hospital Infection .

30 Jan 2012

Medicaid drug payment rule change could lead to savings

The Centers for Medicare and Medicaid Services estimates that the federal government could save as much as $17.7 billion over the course of five years as a result of a rule change that shifts more costs to drug makers and pharmacies.

30 Jan 2012

Fat grafting may reduce radiation-induced complications in breast implants

For breast cancer patients who have undergone radiation therapy, a new technique consisting of fat injection followed by implant placement may provide a much-needed alternative for breast reconstruction, reports a study in the February issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).

30 Jan 2012

Newly discovered molecular pathway may explain how AML develops

Researchers at UC Santa Barbara have discovered a molecular pathway that may explain how a particularly deadly form of cancer develops. The discovery may lead to new cancer therapies that reprogram cells instead of killing them. The findings are published in a recent paper in the Journal of Biological Chemistry.

30 Jan 2012

Previewing inaugural Malaria Policy Advisory Committee

The Malaria Policy Advisory Committee, convened by the WHO Global Malaria Programme and composed of 15 malaria experts, will hold its first meeting January 31 through February 2 in Geneva, according to this article in Malaria Journal, which is a prelude to a series on the group's policy recommendations and supporting evidence that will be published following each biannual meeting.

30 Jan 2012

ASI's GenASIs for detection of chromosomal aberrations in bladder cancer receives FDA approval

Applied Spectral Imaging (ASI) announced today that ASI's GenASIs Scan & Analysis, SpotScan used for the detection of chromosomal aberrations in bladder cancer has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.

30 Jan 2012

NSABB explanation of decision to recommend censoring of bird flu research expected soon

The NIH is expected on February 1 to release a statement explaining how the U.S. National Science Advisory Board for Biosecurity (NSABB) reached a decision late last year to recommend "that two scientific papers describing research that created strains of bird flu potentially transmissible in humans should be published only if key details are omitted," for fear "that terrorists or hostile nations could learn how to cause a pandemic," a New York Times editorial by Philip Boffey, Times science editorial writer, states.

30 Jan 2012

Researchers identify two genetic mutations responsible for brain cancer in children

An international research team led by the Research Institute of the McGill University Health Centre (RI MUHC) has made a major genetic breakthrough that could change the way pediatric cancers are treated in the future.

30 Jan 2012

OIG: Data inconclusive about why docs leave Medicare

A report released last week by the Health and Human Services' Office of the Inspector General found that limited data made it difficult to gauge if issues surrounding the uncertainty of physician pay is driving doctors to opt out of Medicare.

30 Jan 2012

KineMed, Pfizer enter research collaboration on metabolic diseases

KineMed, Inc. today announced a non-exclusive research collaboration with Pfizer Inc. for the advancement of novel approaches towards metabolic disease, in particular Type II Diabetes.

30 Jan 2012

Allos seeks re-examination of EMA CHMP opinion on FOLOTYN for PTCL

Allos Therapeutics, Inc. today announced that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in January by the EMA's Committee For Medicinal Products for Human Use (CHMP) for conditional approval of FOLOTYN (pralatrexate injection) for the treatment of patients with peripheral T-cell lymphoma (PTCL) whose disease has progressed after at least one prior systemic therapy.

30 Jan 2012